Package 13107-282-05

Brand: clorazepate dipotassium

Generic: clorazepate dipotassium
NDC Package

Package Facts

Identity

Package NDC 13107-282-05
Digits Only 1310728205
Product NDC 13107-282
Description

500 TABLET in 1 BOTTLE, PLASTIC (13107-282-05)

Marketing

Marketing Status
Marketed Since 2023-09-23
Brand clorazepate dipotassium
Generic clorazepate dipotassium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "69451c35-dd9a-4690-8d5e-4dcfa8837620", "openfda": {"unii": ["63FN7G03XY"], "rxcui": ["197464", "197465", "197466"], "spl_set_id": ["69451c35-dd9a-4690-8d5e-4dcfa8837620"], "manufacturer_name": ["Aurolife Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (13107-282-01)", "package_ndc": "13107-282-01", "marketing_start_date": "20230923"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE, PLASTIC (13107-282-05)", "package_ndc": "13107-282-05", "marketing_start_date": "20230923"}], "brand_name": "CLORAZEPATE DIPOTASSIUM", "product_id": "13107-282_69451c35-dd9a-4690-8d5e-4dcfa8837620", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "13107-282", "dea_schedule": "CIV", "generic_name": "CLORAZEPATE DIPOTASSIUM", "labeler_name": "Aurolife Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CLORAZEPATE DIPOTASSIUM", "active_ingredients": [{"name": "CLORAZEPATE DIPOTASSIUM", "strength": "3.75 mg/1"}], "application_number": "ANDA071858", "marketing_category": "ANDA", "marketing_start_date": "20230923", "listing_expiration_date": "20261231"}